These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 3298477)
21. Survival of BALB/c mice after intraperitoneal infection with Mycobacterium lepraemurium. Levy L; Ng H; Welch TM Isr J Med Sci; 1980 Nov; 16(11):780-4. PubMed ID: 7002862 [TBL] [Abstract][Full Text] [Related]
22. Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice. Matsiota-Bernard P; Mahana W; Avrameas S; Nauciel C Immunology; 1993 Jul; 79(3):375-80. PubMed ID: 8406566 [TBL] [Abstract][Full Text] [Related]
23. Do antibodies to phospholipid antigens play any role in murine leprosy? Rojas-Espinosa O; Wek Rodriguez K; Vargas Hernandez JA; Arce Paredes P Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):453-9. PubMed ID: 10700921 [TBL] [Abstract][Full Text] [Related]
24. The effect of exogenous peroxidase on the evolution of murine leprosy. Rojas-Espinosa O; Wek-Rodríguez K; Arce-Paredes P Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):191-200. PubMed ID: 12483967 [TBL] [Abstract][Full Text] [Related]
25. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients. Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751 [TBL] [Abstract][Full Text] [Related]
26. Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity. Løvik M; Closs O Clin Exp Immunol; 1984 Jul; 57(1):115-22. PubMed ID: 6378458 [TBL] [Abstract][Full Text] [Related]
27. Restored pathogenicity of attenuated Mycobacterium lepraemurium in mice. Nomaguchi H; Kohsaka K; Miyata Y; Mori T; Ito T Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):446-52. PubMed ID: 3528347 [TBL] [Abstract][Full Text] [Related]
28. Low responsiveness to MLM bacilli associated with an impaired macrophage function in CBA/J mice. Saito N; Natori T Exp Clin Immunogenet; 1985; 2(1):24-35. PubMed ID: 2978828 [TBL] [Abstract][Full Text] [Related]
29. Immunization of highly susceptible C3H mice with ultrasonicated Mycobacterium lepraemurium (MLM) bacilli facilitates the development of increased resistance during MLM infection. Løvik M; Closs OM; Haugen OA Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):351-61. PubMed ID: 6541203 [TBL] [Abstract][Full Text] [Related]
30. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. I. Analysis of antibody responses. Correa-Oliveira R; Sher A; James SL J Immunol; 1984 Sep; 133(3):1581-6. PubMed ID: 6747298 [TBL] [Abstract][Full Text] [Related]
31. The histopathology of tissues in "resistant" and "susceptible" strains of mice infected with a moderate dose of Mycobacterium lepraemurium. Adu HO; Turk JL; Curtis J J Pathol; 1983 Mar; 139(3):275-90. PubMed ID: 6339701 [TBL] [Abstract][Full Text] [Related]
32. Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro. Brett SJ; Butler R Immunology; 1986 Nov; 59(3):339-45. PubMed ID: 2431995 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of complement activity in murine leprosy. Rojas-Espinosa O; Oltra A; Arce P; Mendez P Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):605-12. PubMed ID: 1802943 [TBL] [Abstract][Full Text] [Related]
34. Immune response to Mycobacterium leprae: further studies on the assessment of humoral immune response in mice. Navalkar RG Zentralbl Bakteriol A; 1980 Aug; 247(3):364-73. PubMed ID: 6999803 [TBL] [Abstract][Full Text] [Related]
35. Experimental murine leprosy. IX. Antibodies against Mycobacterium lepraemurium in C3H and C57BL mice with murine leprosy and in patients with lepromatous leprosy. Closs O; Kronvall G Scand J Immunol; 1975; 4(7):735-40. PubMed ID: 1105768 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy. Turcotte R; Chaput J; Lemieux S Clin Exp Immunol; 1984 Apr; 56(1):97-104. PubMed ID: 6370521 [TBL] [Abstract][Full Text] [Related]
37. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population. Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of T-cell unresponsiveness in leprosy. Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239 [TBL] [Abstract][Full Text] [Related]
39. Antibody-mediated immunity in CFW mice infected with Mycobacterium lepraemurium. Humoral immune response in murine leprosy. Rojas-Espinosa O; Casoluengo-Méndez M; Díaz GV Clin Exp Immunol; 1976 Dec; 26(3):381-7. PubMed ID: 795574 [TBL] [Abstract][Full Text] [Related]
40. Differences in cell-mediated immune responses of 'high-resistance' and 'low-resistance' mice to a nonpathogenic mycobacterium. Adu HO; Curtis J; Turk JL Scand J Immunol; 1981 Nov; 14(5):467-80. PubMed ID: 7038853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]